669 features were associated with at least one phenotype (clinical diagnosis of AD, P-tau181 biomarker positive for AD or biological AD, plasma levels of Αβ42/Αβ 40 ratio, NfL, P-tau181 and GFAP). This evidence concerns the gene GFAP and Alzheimer disease.